VANCOUVER: To help people recover from injuries, Romania-born software engineer has turned tedious physical rehabilitation exercises into a game, which he showcased at TED Conference.
Engineer Mihaiu showed how the game can be played on the motion-sensing video game platform Kinect for Micosoft’s Xbox. “We need to come up with solutions to get patients motivated to get better,” Mihaiu told AFP. “No one likes treatment, but if we can make it in a way where people don’t think it is cumbersome they will get better faster and save costs.”
Mihaiu and colleagues devised the software application to work with physical therapists to customize motion-control games to reward patients for doing prescribed movements.
The system, which is called Mira (Medical Interactive Recovery Assistant), is currently designed for play offline in clinics. Its makers plan to create an online version that people could use at home, with performance data shared with therapists. “We don’t want to replace the physical therapists,” Mihaiu said. “We want to develop a digital pill that can be prescribed to help the patient get better.”
Mira is being tried in clinics in Britain and Romania, with an annual subscription price of several thousand dollars, Mihaiu said.
He said that there is a large market in the rehabilitation industry because unlike consumer-focused fitness games, medical games come with endorsement and follow-up by doctors, nurses or therapists.
Ubisoft early in March unveiled a tablet video game crafted as a prescription for a medical condition known as “lazy eye,” blending the worlds of play and treatment.
The France-based video game titan created “Dig Rush” in collaboration with US health technology startup Amblyotech, using treatment technology from innovators at McGill University in Canada.
The game targets amblyopia, a condition in which a person’s eye and brain are out of sync. It is reported to affect three percent of the global population.
The game is like a “syringe of the future; where you use a visual display to administer a drug to a patient,” Amblyotech chief executive Joseph Koziak said at a game developers conference in San Francisco.
